⌘K

Login Start Free

Home/Filings/4/0001213900-25-001168

4//SEC Filing

KIDRON NADAV 4

Accession 0001213900-25-001168

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:10 PM ET

Size

5.7 KB

Accession

0001213900-25-001168

Insider Transaction Report

Form 4

Period: 2025-01-02

ORAMED PHARMACEUTICALS INC.ORMP

DirectorPresident and CEO

Transactions

Award
Common Stock
2025-01-02+433,500→ 2,259,598 total

Holdings

Common Stock
(indirect: By wholly-owned corporation)
126,000

Footnotes (1)

[F1]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 36,125 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001351779

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 4:10 PM ET
Size: 5.7 KB

View on SEC.gov